75
Participants
Start Date
March 5, 2021
Primary Completion Date
November 8, 2023
Study Completion Date
October 28, 2025
Avatrombopag
Oral avatrombopag tablet or sprinkle capsule
Placebo
Placebo comparator tablet or sprinkle capsule
Site 801, Budapest
Site 802, Miskolc
Site 803, Pécs
Site 304, Berlin
Site 121, Philadelphia
Site 120, Wilmington
Site 705, Denizli
Site 302, Hamburg
Site 952, Vinnytsia
Site 303, Kiel
Site 113, Durham
Site 118, Charlotte
Site 116, Atlanta
Site 201, Toulouse
Site 117, Gainesville
Site 708, Mersin
Site 709, Istanbul
Site 710, Istanbul
Site 703, Istanbul
Site 707, Izmir
Site 114, Jackson
Site 106, Columbus
Site 105, Minneapolis
Site 954, Kharkiv
Site 107, Peoria
Site 202, Paris
Site 115, Houston
Site 301, Freiburg im Breisgau
Site 111, Aurora
Site 112, Phoenix
Site 102, Las Vegas
Site 103, Long Beach
Site 119, Orange
Site 101, San Francisco
Site 109, Sacramento
Site 904, Moscow
Site 906, Moscow
Site 901, Moscow
Site 905, Saint Petersburg
Site 903, Volgograd
Site 907, Chelyabinsk
Site 902, Nizhny Novgorod
Site 104, Boston
Site 108, Morristown
Site 110, Providence
Site 502, Bydgoszcz
Site 503, Warsaw
Site 505, Zabrze
Site 501, Olsztyn
Site 504, Lodz
Site 701, Adana
Site 704, Ankara
Site 706, Antalya
Site 702, Antalya
Site 405, Birmingham
Site 408, Liverpool
Site 403, London
Site 410, London
Site 407, London
Site 402, Manchester
Site 401, Sheffield
Site 406, Cardiff
Sobi, Inc.
INDUSTRY